You are viewing the site in preview mode
Skip to main content
| |
SOM1 (n = 11)
|
SOM2 (n = 15)
|
SOM3 (n = 31)
|
Pearson Chi-square
|
p-value
|
|---|
|
Grade
|
|
Low (I-II)
|
3
|
10
|
20
| | |
|
High (III)
|
7
|
4
|
8
|
5.978
|
0.05
|
|
Missing: 5
| | | | | |
|
ERα
|
|
ERα−
|
0
|
2
|
2
| | |
|
ERα+
|
10
|
13
|
29
|
1.658
|
0.436
|
|
Missing: 1
| | | | | |
|
Lymp node metastasis
|
|
No
|
3
|
6
|
11
| | |
|
Yes
|
5
|
6
|
12
|
0.845
|
0.336
|
|
Missing: 14
| | | | | |
|
Histology
|
|
Ductal
|
7
|
12
|
20
| | |
|
Lobular
|
4
|
2
|
6
| | |
|
Ductal + lobular
|
0
|
0
|
1
| | |
|
Other
|
0
|
1
|
4
|
4.574
|
0.599
|
|
Missing:0
| | | | | |
- The distribution of cancers with specific clinical characteristics, including cancer type, ERα status, lymph node metastasis and grade in each SOM-group. Significance was calculated by using Pearson chi-square
